Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 4
2006 7
2007 2
2008 3
2009 8
2010 7
2011 1
2012 7
2013 5
2014 6
2015 7
2016 14
2017 13
2018 17
2019 15
2020 23
2021 17
2022 12
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.
Sato T, Yoshida K, Toki T, Kanezaki R, Terui K, Saiki R, Ojima M, Ochi Y, Mizuno S, Yoshihara M, Uechi T, Kenmochi N, Tanaka S, Matsubayashi J, Kisai K, Kudo K, Yuzawa K, Takahashi Y, Tanaka T, Yamamoto Y, Kobayashi A, Kamio T, Sasaki S, Shiraishi Y, Chiba K, Tanaka H, Muramatsu H, Hama A, Hasegawa D, Sato A, Koh K, Karakawa S, Kobayashi M, Hara J, Taneyama Y, Imai C, Hasegawa D, Fujita N, Yoshitomi M, Iwamoto S, Yamato G, Saida S, Kiyokawa N, Deguchi T, Ito M, Matsuo H, Adachi S Prof, Hayashi Y, Taga T, Moriya Saito A, Horibe K, Watanabe K, Tomizawa D, Miyano S, Takahashi S, Ogawa S, Ito E. Sato T, et al. Among authors: yamamoto y. Blood. 2024 Mar 21:blood.2023022247. doi: 10.1182/blood.2023022247. Online ahead of print. Blood. 2024. PMID: 38513239
Keratin Microspheres as Promising Tool for Targeting Follicular Growth.
Bejaoui M, Heah WY, Oliva Mizushima AK, Nakajima M, Yamagishi H, Yamamoto Y, Isoda H. Bejaoui M, et al. Among authors: yamamoto y. ACS Appl Bio Mater. 2024 Mar 18;7(3):1513-1525. doi: 10.1021/acsabm.3c00956. Epub 2024 Feb 14. ACS Appl Bio Mater. 2024. PMID: 38354359
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Yamamoto Y, Imai R, Kuranari Y, Tohmoto K, Hasegawa Y, Akasaki Y, Murayama Y, Miyake K, Sasaki H. Tanaka T, et al. Among authors: yamamoto y. J Neurooncol. 2024 Feb;166(3):557-567. doi: 10.1007/s11060-023-04544-8. Epub 2024 Jan 31. J Neurooncol. 2024. PMID: 38291182 Free PMC article. Clinical Trial.
180 results